Literature DB >> 26886313

Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz.

Eduardo Gomes Rodrigues de Sousa1, Erika Martins de Carvalho2, Rosane Aguiar da Silva San Gil3, Tereza Cristina Dos Santos2, Leandro Bandeira Borré4, Osvaldo Andrade Santos-Filho2, Javier Ellena5.   

Abstract

Samples of efavirenz (EFZ) were evaluated to investigate the influence of the micronization process on EFZ stability. A combination of X-ray diffraction, thermal analysis, FTIR, observations of isotropic chemical shifts of (1)H in distinct solvents, their temperature dependence and spin-lattice relaxation time constants (T1), solution (1D and 2D) (13)C nuclear magnetic resonance (NMR), and solid-state (13)C NMR (CPMAS NMR) provides valuable structural information and structural elucidation of micronized EFZ and heptane-recrystallized polymorphs (EFZ/HEPT). This study revealed that the micronization process did not affect the EFZ crystalline structure. It was observed that the structure of EFZ/HEPT is in the same form as that obtained from ethyl acetate/hexane, as shown in the literature. A comparison of the solid-state NMR spectra revealed discrepancies regarding the assignments of some carbons published in the literature that have been resolved.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (1)H NMR; (13)C CPMAS NMR; efavirenz; polymorphism

Mesh:

Substances:

Year:  2016        PMID: 26886313     DOI: 10.1016/j.xphs.2015.10.006

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Inclusion Compound of Efavirenz and γ-Cyclodextrin: Solid State Studies and Effect on Solubility.

Authors:  Susana Santos Braga; Firas El-Saleh; Karyna Lysenko; Filipe A Almeida Paz
Journal:  Molecules       Date:  2021-01-20       Impact factor: 4.411

2.  Solid-State Study of the Structure, Dynamics, and Thermal Processes of Safinamide Mesylate─A New Generation Drug for the Treatment of Neurodegenerative Diseases.

Authors:  Tomasz Pawlak; Marcin Oszajca; Małgorzata Szczesio; Marek J Potrzebowski
Journal:  Mol Pharm       Date:  2021-12-02       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.